PEG-话题@MedSci

#PEG#

56篇内容 | 2095人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1533484, encodeId=4242153348445, content=<a href='/topic/show?id=e59c1400060' target=_blank style='color:#2F92EE;'>#PEG#</a>, objectTitle=ACS Appl Mater Interfaces：李帮经课题组在超分子前药mPEG-β-CD/Fc-CPT的自组装及释放行为研究上获进展, objectType=article, longId=97581, objectId=dc9f9e581d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc9f9e581d8, replyNumber=0, likeNumber=0, createdTime=2017-05-01, rootId=0, userName=wleon8899, userId=bbc812457783, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc9f9e581d8, moduleTitle=ACS Appl Mater Interfaces：李帮经课题组在超分子前药mPEG-β-CD/Fc-CPT的自组装及释放行为研究上获进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc9f9e581d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533483, encodeId=b3741533483f2, content=<a href='/topic/show?id=e59c1400060' target=_blank style='color:#2F92EE;'>#PEG#</a>, objectTitle=2016NICE技术评估指南：Certolizumab pego用于治疗TNFα抑制剂治疗反应不敏感类风湿性关节炎（TA415）发布, objectType=article, longId=81115, objectId=cd38811156e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd38811156e, replyNumber=0, likeNumber=66, createdTime=2016-10-28, rootId=0, userName=wleon8899, userId=bbc812457783, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd38811156e, moduleTitle=2016NICE技术评估指南：Certolizumab pego用于治疗TNFα抑制剂治疗反应不敏感类风湿性关节炎（TA415）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd38811156e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533482, encodeId=41871533482c5, content=<a href='/topic/show?id=e59c1400060' target=_blank style='color:#2F92EE;'>#PEG#</a>, objectTitle=2016聚乙二醇化重组人粒细胞刺激因子（PEG-rhG-CSF）临床应用中国专家共识发布, objectType=article, longId=79326, objectId=b950e932663, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b950e932663, replyNumber=0, likeNumber=62, createdTime=2016-10-07, rootId=0, userName=wleon8899, userId=bbc812457783, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b950e932663, moduleTitle=2016聚乙二醇化重组人粒细胞刺激因子（PEG-rhG-CSF）临床应用中国专家共识发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b950e932663)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533481, encodeId=581b1533481a4, content=<a href='/topic/show?id=e59c1400060' target=_blank style='color:#2F92EE;'>#PEG#</a>, objectTitle=Stroke: 美国脑出血后行PEG受到种族和家庭收入的影响, objectType=article, longId=69111, objectId=ae016911141, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae016911141, replyNumber=0, likeNumber=93, createdTime=2016-05-26, rootId=0, userName=wleon8899, userId=bbc812457783, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae016911141, moduleTitle=Stroke: 美国脑出血后行PEG受到种族和家庭收入的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae016911141)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533480, encodeId=b1141533480da, content=<a href='/topic/show?id=e59c1400060' target=_blank style='color:#2F92EE;'>#PEG#</a>, objectTitle=丙肝鸡尾酒Zepatier头对头III期治疗基因型1/4丙肝疗效及安全性显著优于sofosbuvir+pegIFN/RBV方案, objectType=article, longId=66962, objectId=bde56696205, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bde56696205, replyNumber=0, likeNumber=68, createdTime=2016-04-23, rootId=0, userName=wleon8899, userId=bbc812457783, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bde56696205, moduleTitle=丙肝鸡尾酒Zepatier头对头III期治疗基因型1/4丙肝疗效及安全性显著优于sofosbuvir+pegIFN/RBV方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bde56696205)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533479, encodeId=4fa715334e90a, content=<a href='/topic/show?id=e59c1400060' target=_blank style='color:#2F92EE;'>#PEG#</a>, objectTitle=Lancet Oncol：Etirinotecan pegol治疗乳腺癌效果分析, objectType=article, longId=57421, objectId=f6435e4216a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6435e4216a, replyNumber=0, likeNumber=57, createdTime=2015-10-20, rootId=0, userName=wleon8899, userId=bbc812457783, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6435e4216a, moduleTitle=Lancet Oncol：Etirinotecan pegol治疗乳腺癌效果分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6435e4216a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533478, encodeId=06e915334e8bc, content=<a href='/topic/show?id=e59c1400060' target=_blank style='color:#2F92EE;'>#PEG#</a>, objectTitle=Am Heart J：替格瑞洛能显著降低有心梗史患者的主要不良心血管事件（PEGASUS-TIMI 54研究）, objectType=article, longId=45642, objectId=8a344564298, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a344564298, replyNumber=0, likeNumber=62, createdTime=2015-01-18, rootId=0, userName=wleon8899, userId=bbc812457783, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a344564298, moduleTitle=Am Heart J：替格瑞洛能显著降低有心梗史患者的主要不良心血管事件（PEGASUS-TIMI 54研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a344564298)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533477, encodeId=647a15334e752, content=<a href='/topic/show?id=e59c1400060' target=_blank style='color:#2F92EE;'>#PEG#</a>, objectTitle=JAMA Intern Med：PEG溶液疗法治疗急性肝性脑病效果好, objectType=article, longId=42360, objectId=cd924236039, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd924236039, replyNumber=0, likeNumber=70, createdTime=2014-11-12, rootId=0, userName=wleon8899, userId=bbc812457783, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd924236039, moduleTitle=JAMA Intern Med：PEG溶液疗法治疗急性肝性脑病效果好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd924236039)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533476, encodeId=c10c15334e6d7, content=<a href='/topic/show?id=e59c1400060' target=_blank style='color:#2F92EE;'>#PEG#</a>, objectTitle=PNAS：新药（ADI-PEG20）的抗癌新机制, objectType=article, longId=39103, objectId=ad6b3910373, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad6b3910373, replyNumber=0, likeNumber=92, createdTime=2014-08-16, rootId=0, userName=wleon8899, userId=bbc812457783, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad6b3910373, moduleTitle=PNAS：新药（ADI-PEG20）的抗癌新机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad6b3910373)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533475, encodeId=b31015334e598, content=<a href='/topic/show?id=e59c1400060' target=_blank style='color:#2F92EE;'>#PEG#</a>, objectTitle=礼来基础胰岛素peglispro III期研究疗效优于来得时（IMAGINE研究）, objectType=article, longId=34819, objectId=ffd13481911, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ffd13481911, replyNumber=0, likeNumber=64, createdTime=2014-05-17, rootId=0, userName=wleon8899, userId=bbc812457783, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ffd13481911, moduleTitle=礼来基础胰岛素peglispro III期研究疗效优于来得时（IMAGINE研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ffd13481911)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533474, encodeId=74d715334e4d6, content=<a href='/topic/show?id=e59c1400060' target=_blank style='color:#2F92EE;'>#PEG#</a>, objectTitle=EASL 2014：延长PEG-IFNα-2a+替诺福韦疗程对丁肝预后无益, objectType=article, longId=33343, objectId=0e45333432d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e45333432d, replyNumber=0, likeNumber=79, createdTime=2014-04-16, rootId=0, userName=wleon8899, userId=bbc812457783, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e45333432d, moduleTitle=EASL 2014：延长PEG-IFNα-2a+替诺福韦疗程对丁肝预后无益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e45333432d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533473, encodeId=7c8315334e343, content=<a href='/topic/show?id=e59c1400060' target=_blank style='color:#2F92EE;'>#PEG#</a>, objectTitle=IJP：生长激素拮抗剂N-末端PEG药效学研究获进展, objectType=article, longId=25741, objectId=79e125e4135, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79e125e4135, replyNumber=0, likeNumber=67, createdTime=2013-10-25, rootId=0, userName=wleon8899, userId=bbc812457783, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79e125e4135, moduleTitle=IJP：生长激素拮抗剂N-末端PEG药效学研究获进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79e125e4135)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533472, encodeId=95a415334e221, content=<a href='/topic/show?id=e59c1400060' target=_blank style='color:#2F92EE;'>#PEG#</a>, objectTitle=ASCO 2013：香港中文大学莫树锦等证实pEGFR mut能有效预测非小细胞肺癌患者的预后, objectType=article, longId=19176, objectId=124a191e6be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=124a191e6be, replyNumber=0, likeNumber=76, createdTime=2013-05-24, rootId=0, userName=wleon8899, userId=bbc812457783, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=124a191e6be, moduleTitle=ASCO 2013：香港中文大学莫树锦等证实pEGFR mut能有效预测非小细胞肺癌患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=124a191e6be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533471, encodeId=a94615334e1a2, content=<a href='/topic/show?id=e59c1400060' target=_blank style='color:#2F92EE;'>#PEG#</a>, objectTitle=ASCO2013:利用循环肿瘤细胞可检测Etirinotecan pegol治疗转移性乳腺癌的相关药效, objectType=article, longId=19005, objectId=7a8b1900593, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a8b1900593, replyNumber=0, likeNumber=71, createdTime=2013-05-22, rootId=0, userName=wleon8899, userId=bbc812457783, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a8b1900593, moduleTitle=ASCO2013:利用循环肿瘤细胞可检测Etirinotecan pegol治疗转移性乳腺癌的相关药效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a8b1900593)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533470, encodeId=69ed15334e008, content=<a href='/topic/show?id=e59c1400060' target=_blank style='color:#2F92EE;'>#PEG#</a>, objectTitle=中日对比：PEG IFN治疗慢性丙肝的疗效很大化, objectType=article, longId=7530, objectId=f404e53062, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f404e53062, replyNumber=0, likeNumber=70, createdTime=2012-07-04, rootId=0, userName=wleon8899, userId=bbc812457783, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f404e53062, moduleTitle=中日对比：PEG IFN治疗慢性丙肝的疗效很大化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f404e53062)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533469, encodeId=63e91533469dd, content=<a href='/topic/show?id=e59c1400060' target=_blank style='color:#2F92EE;'>#PEG#</a>, objectTitle=Affymax公司药物peginesatide打破安进公司抗贫血药物市场垄断地位, objectType=article, longId=5400, objectId=179c5400ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=179c5400ce, replyNumber=0, likeNumber=82, createdTime=2012-04-18, rootId=0, userName=wleon8899, userId=bbc812457783, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=179c5400ce, moduleTitle=Affymax公司药物peginesatide打破安进公司抗贫血药物市场垄断地位, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=179c5400ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

PEG

2020-05-29

wleon8899 (审核中...)

前往app查看评论内容

#PEG#

ACS Appl Mater Interfaces：李帮经课题组在超分子前药mPEG-β-CD/Fc-CPT的自组装及释放行为研究上获进展

2017-05-01

wleon8899 (审核中...)

前往app查看评论内容

#PEG#

2016NICE技术评估指南：Certolizumab pego用于治疗TNFα抑制剂治疗反应不敏感类风湿性关节炎（TA415）发布

2016-10-28

wleon8899 (审核中...)

前往app查看评论内容

#PEG#

2016聚乙二醇化重组人粒细胞刺激因子（PEG-rhG-CSF）临床应用中国专家共识发布

2016-10-07

wleon8899 (审核中...)

前往app查看评论内容

#PEG#

Stroke: 美国脑出血后行PEG受到种族和家庭收入的影响

2016-05-26

wleon8899 (审核中...)

前往app查看评论内容

#PEG#

丙肝鸡尾酒Zepatier头对头III期治疗基因型1/4丙肝疗效及安全性显著优于sofosbuvir+pegIFN/RBV方案

2016-04-23

wleon8899 (审核中...)

前往app查看评论内容

#PEG#

Lancet Oncol：Etirinotecan pegol治疗乳腺癌效果分析

2015-10-20

wleon8899 (审核中...)

前往app查看评论内容

#PEG#

Am Heart J：替格瑞洛能显著降低有心梗史患者的主要不良心血管事件（PEGASUS-TIMI 54研究）

2015-01-18

wleon8899 (审核中...)

前往app查看评论内容

#PEG#

JAMA Intern Med：PEG溶液疗法治疗急性肝性脑病效果好

2014-11-12

wleon8899 (审核中...)

前往app查看评论内容

#PEG#

PNAS：新药（ADI-PEG20）的抗癌新机制

2014-08-16

wleon8899 (审核中...)

前往app查看评论内容

#PEG#

礼来基础胰岛素peglispro III期研究疗效优于来得时（IMAGINE研究）

2014-05-17

wleon8899 (审核中...)

前往app查看评论内容

#PEG#

EASL 2014：延长PEG-IFNα-2a+替诺福韦疗程对丁肝预后无益

2014-04-16

wleon8899 (审核中...)

前往app查看评论内容

#PEG#

IJP：生长激素拮抗剂N-末端PEG药效学研究获进展

2013-10-25

wleon8899 (审核中...)

前往app查看评论内容

#PEG#

ASCO 2013：香港中文大学莫树锦等证实pEGFR mut能有效预测非小细胞肺癌患者的预后

2013-05-24

wleon8899 (审核中...)

前往app查看评论内容

#PEG#

ASCO2013:利用循环肿瘤细胞可检测Etirinotecan pegol治疗转移性乳腺癌的相关药效

2013-05-22

wleon8899 (审核中...)

前往app查看评论内容

#PEG#

中日对比：PEG IFN治疗慢性丙肝的疗效很大化

2012-07-04

wleon8899 (审核中...)

前往app查看评论内容

#PEG#

Affymax公司药物peginesatide打破安进公司抗贫血药物市场垄断地位

2012-04-18

科室
- - 订阅+
  - 更多科室
工具
服务